MedUni Vienna researchers discover important regulators in development of stem cells

NewsGuard 100/100 Score

A team of researchers at the MedUni Vienna's Institute of Medical Genetics has discovered that two genes (TSC/Tuberin and PRAS40) are extremely important regulators in the development of stem cells: if these genes are switched off, the stem cells do not develop but instead die a programmed cell death.

The group led by Markus Hengstschläger, Director of the Institute of Medical Genetics at the MedUni Vienna, has been able to prove in a paper now published in the highly-respected journal "Human Molecular Genetics", that stem cells need both of these proteins to develop and be involved in the regeneration and differentiation processes in cells.

The human body maintains a stable equilibrium between cell death and the breakdown of tissue and the regeneration of tissue from stem cells. Stem cells have the potential to develop into other types of cells such as skin, muscle or nerve cells and are therefore crucial for the rebuilding of tissue. A human stomach cells, for example, lives only two days. Skin cells live for up to four weeks. A lung cell dies after around 80 days and a red blood cell dies after around 120 days.

The two proteins TSC (tuberin) and PRAS40 are crucial for this development, deciding whether the stem cell develops correctly or undergoes apoptosis, a form of programmed cell death. They act, as it were, as 'gatekeepers'.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New influenza vaccine strategies aim to enhance protection with T-cell responses